Alibaba
BABA
Broadcom
AVGO
Meta Platforms
META
Alphabet-C
GOOG
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
AKBA Akebia Therapeutics
- 2.3800
- -0.0100-0.42%
Close Jan 24 16:00 ET
- 2.3700
- -0.0100-0.42%
Post 20:01 ET
519.27MMarket Cap-10.82P/E (TTM)
2.4050High2.3600Low1.62MVolume2.4000Open2.3900Pre Close3.86MTurnover0.82%Turnover RatioLossP/E (Static)218.18MShares2.480052wk High-10.30P/B471.89MFloat Cap0.800052wk Low--Dividend TTM198.27MShs Float31.0000Historical High--Div YieldTTM1.88%Amplitude0.2410Historical Low2.3860Avg Price1Lot Size
About Akebia Therapeutics Company
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
Company Profile
SymbolAKBA
Company NameAkebia Therapeutics
Listing DateMar 20, 2014
Issue Price17.00
Founded2007
CEOMr. John P. Butler
MarketNASDAQ
Employees167
Fiscal Year Ends12-31
Address245 First Street,Suite 1400
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-871-2098
Websitehttp://www.akebia.com
Company Executives
- Name
- Position
- Salary
- John P. Butler
- Director, President and Chief Executive Officer
- 2.78M
- Dr. Steven Keith Burke, M.D.
- Senior Vice President, Research and Development and Chief Medical Officer
- 1.21M
- Richard C. Malabre
- Chief Accounting Officer
- --
- Nicholas Grund
- Senior Vice President and Chief Commercial Officer
- --
- Erik John Ostrowski
- Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer
- --
- Adrian Adams
- Chairman of the Board
- 171.63K
- Michael W. Rogers
- Independent Director
- 145.79K
- Ronald E. Frieson
- Independent Director
- 147.97K
- LeAnne M. Zumwalt
- Independent Director
- 143.31K
- Cynthia Smith
- Independent Director
- 151.50K
- Dr. Steven C. Gilman, PhD
- Independent Director
- 139.87K
- Dr. Myles Wolf, M.D.
- Independent Director
- 144.43K
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.